Tevogen Bio Holdings, Inc. (TVGN)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$7.34+2.37%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · TVGN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | FY 2021 | |
|---|---|---|---|---|---|---|
| Operating Expenses & Income | ||||||
| R&D Expenses | 11.6 | 11.1 | 31.0 | 4.4 | — | — |
| Operating Income | (21.4) | (26.1) | (53.6) | (8.8) | — | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | — | 0.2 | 1.2 | — | — |
| Interest & Investment Income | — | — | — | 2.7 | 4.9 | — |
| Net Interest Expenses | — | — | — | (1.5) | — | — |
| Other Non-Operating Income / Expenses | — | — | — | 2.2 | 5.4 | — |
| Income Tax Expense | — | 0.0 | — | — | — | — |
| Net Income | ||||||
| Net Income | (21.6) | (26.3) | (13.7) | (60.5) | 4.4 | — |
| Per Share | ||||||
| Basic EPS | (5.64) | (8.08) | (0.07) | (2.44) | — | — |
| Diluted EPS | (5.64) | (8.08) | (0.07) | (2.44) | — | — |
| Basic Weighted Avg Shares | 3.8 | 3.3 | 146.7 | 24.8 | — | — |
| Diluted Weighted Avg Shares | 3.8 | 3.3 | 146.7 | 24.8 | — | — |
| Supplemental | ||||||
| EBIT | (21.4) | (26.1) | (53.6) | (8.8) | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.